Molecular biomarkers in early stage lung cancer

Low dose computed tomography (LDCT) screening, together with the recent advances in targeted and immunotherapies, have shown to improve non-small cell lung cancer (NSCLC) survival. Furthermore, screening has increased the number of early stage-detected tumors, allowing for surgical resection and mul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Lung Cancer Res
Main Authors: Rodríguez, María, Ajona, Daniel, Seijo, Luis M., Sanz, Julián, Valencia, Karmele, Corral, Jesús, Mesa-Guzmán, Miguel, Pío, Rubén, Calvo, Alfonso, Lozano, María D., Zulueta, Javier J., Montuenga, Luis M.
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2021
Assuntos:
Review Article on Implementation of CT-based Screening of Lung Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947407/
https://ncbi.nlm.nih.gov/pubmed/33718054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-750
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados